Bouter KEC, van Bommel EJM, Jansen H, van Harskamp D, et al. The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well controlled plasma LDL cholesterol. Diabetes Obes Metab 2020 Feb 5. doi: 10.1111/dom.13990.
PMID: 32026592